Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
833.00    11.50 (1.40%)
Bid:
830.00
Ask:
833.50
Spread: 3.50 (0.422%)
Market Cap: £959.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

12 Apr 2017 07:00

RNS Number : 2464C
Kainos Group plc
12 April 2017
Β 

12 April 2017

Β 

Kainos Group plc

Β 

("Kainos" or "the Company")

Β 

Trading Update

Β 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2017.

Β 

Trading in the year ended 31 March 2017 has continued to be in line with market expectations; the Company has experienced good growth across all divisions, and remains well positioned in its core markets.

Β 

The increasing trends towards digitisation and adoption of enterprise Software as a Service (SaaS) solutions have continued to generate strong demand for the Company's Digital Services in both public and commercial markets in the UK and Europe.

Β 

Growth in Digital Platforms remains solid, supported by sustained momentum of Kainos WorkSmart contract wins, although limited funding in the UK's NHS continues to moderate short term growth of Kainos Evolve platforms. The Company continues to invest in development, sales and marketing of its Evolve Integrated Care platform.

Β 

Kainos has a robust balance sheet with no debt and strong cash generation. The business has a solid pipeline, which includes a growing level of recurring revenue. Recruitment remains strong, with over 216 people joining Kainos since 1 April 2016, bringing the total number of employees and contractors worldwide to 975 at the end of March 2017.

Β 

The announcement of Kainos results for the year ended 31Β March 2017 will be made on Tuesday 30Β May 2017.

Β 

- ENDS -

Β 

For further information, please contact:

Β 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Brian Gannon, SVP Corporate Development

Β 

Investec Bank plc +44Β 20 7597 5970

Patrick Robb / Dominic Emery

Β 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

Β 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Nicola Krafft

Β 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,000 staff and contractors across eight offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTIBMFTMBMBBJR
Date   Source Headline
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:45 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
1st Dec 20259:27 amRNSTotal Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 202511:39 amRNSDirector/PDMR shareholdings
24th Nov 202511:22 amRNSNotification of Major Holdings
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:50 amRNSRenewal of Share Buyback Programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20252:57 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:49 pmRNSDirector / PDMR shareholdings
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202511:03 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.